Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to KRAS: Moravsky Kras
KRASKirsten Rat Sarcoma
KRASKnowledge Representation for Autonomous Systems
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Elicio's "AMP KRAS vaccine" ELI-002 will enter initial patient studies in pancreatic cancer patients in Q1-2020.
Lung cancer specimens were analyzed for AKT1 (NM_005163), BRAF (NM_004333), EGFR (NM_005228), ERBB2 (NM_004448), KRAS (NM_033360), NRAS (NM_002524), and PIK3CA (NM_006218) genes.
Additionally, the KRAS G12C mutations are present in 14% of NSCLC adenocarcinoma patients, 4% of colorectal cancer patients and subsets of other types of cancer.
class="MsoNormalMISDECLARED class="MsoNormalOn Thursday, KRA said the goods had been gazetted for auction on August 9 2016.
This molecular array allows to identify the most important mutations of KRAS (codons 12, 13, 59, 61, 117, and 146), NRAS (codons 12, 13, 18, 59, 61, 117, and 146), BRAF (codons 594, 600, and 601), and PIK3CA genes (codons 38, 81, 88, 93, 108, 118, 345, 420, 539, 542, 545, 546, 549, 1021, 1025, 1043, 1047, and 1049).
Conclusion: The KRAS gene mutations in codon 12 and 13 are either absent in CRA patients of northern area of Pakistan or their frequency may be very low.These cases may be due to mutations of some other genes or because of some non-genetic environmental factors.
The state of KRAS gene, whether wild-type (normal) or mutated (abnormal), is already known to predict the metastatic colorectal cancer patients' treatment response to anti-EGFR targeted therapy, a treatment inhibiting cell membrane growth factor receptors that are crucial in the control of key cellular transduction pathways and that are often over-expressed in various human tumors including colorectal cancers.
The findings, published in the journal Molecular Cancer Therapeutics, show that using a form of siRNA to halt KRAS not only dramatically stunted the growth of lung and colon cancers in cultured cells and mice but also stopped metastasis -- the main cause of cancer deaths.
PCR amplification of exon1 of Kras gene Master pure (tm)DNA purification kit -cat.
"We are very pleased to receive FDA approval to launch our therascreen KRAS test in the United States and to play a role in transforming the care of colorectal cancer patients.